Phibro Animal Health (PAHC) Tops Q4 EPS by 6c, Beats on Revenues; FY18 EPS/Revenue Mid-Point Guide Above Consensus

Go back to Phibro Animal Health (PAHC) Tops Q4 EPS by 6c, Beats on Revenues; FY18 EPS/Revenue Mid-Point Guide Above Consensus

Phibro Animal Health Corp. (PAHC) PT Lowered to $41 at Piper Jaffray; Reiterates Overweight

September 1, 2017 10:04 AM EDT

Piper Jaffray lowered its price target on Phibro Animal Health Corp. (NASDAQ: PAHC) to $41.00 (from $42.00) while maintaining a Overweight rating following the company's 4Q. PAHC reported top and bottom line upside, where revenue of $195M came in above the Street at $192.5M and adjusted... More